Detalhe da pesquisa
1.
A phase IIb trial of vorinostat in combination with lenalidomide and dexamethasone in patients with multiple myeloma refractory to previous lenalidomide-containing regimens.
Br J Haematol
; 176(3): 440-447, 2017 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-27859001
2.
Pembrolizumab, lenalidomide and dexamethasone post autologous transplant in patients with high-risk multiple myeloma.
Am J Hematol
; 96(11): E430-E433, 2021 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34435374
3.
Phase I study of carfilzomib, lenalidomide, vorinostat, and dexamethasone in patients with relapsed and/or refractory multiple myeloma.
Br J Haematol
; 171(1): 52-9, 2015 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-26018491
4.
Phase 1 study of pomalidomide MTD, safety, and efficacy in patients with refractory multiple myeloma who have received lenalidomide and bortezomib.
Blood
; 121(11): 1961-7, 2013 Mar 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-23243282
5.
Australian wildfires depleted the ozone layer.
Science
; 378(6622): 829-830, 2022 11 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-36423291
6.
TIRAP Ser180Leu polymorphism is associated with Behcet's disease.
Rheumatology (Oxford)
; 50(10): 1760-5, 2011 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-21705416
7.
Vorinostat in Combination With Lenalidomide and Dexamethasone in Lenalidomide-Refractory Multiple Myeloma.
Clin Lymphoma Myeloma Leuk
; 16(10): 558-562, 2016 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-27769558
8.
Carfilzomib as salvage therapy in Waldenstrom macroglobulinemia: a case series.
Leuk Lymphoma
; 59(1): 259-261, 2018 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28583038
9.
Phase II trial of syncopated thalidomide, lenalidomide, and weekly dexamethasone in patients with newly diagnosed multiple myeloma.
Clin Lymphoma Myeloma Leuk
; 12(3): 186-90, 2012 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-22381702
10.
The anion gap and routine serum protein measurements in monoclonal gammopathies.
Clin J Am Soc Nephrol
; 6(12): 2814-21, 2011 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-22157711
11.
Phase I trial of oral vorinostat (suberoylanilide hydroxamic acid, SAHA) in patients with advanced multiple myeloma.
Leuk Lymphoma
; 49(3): 502-7, 2008 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-18297527